Hong Kong biopharmaceutical stocks strengthen, with Zaiding Pharmaceutical rising over 12%
我放心你带套猛
发表于 2024-10-18 11:41:24
190
0
0
On the morning of October 18th, Hong Kong biopharmaceutical stocks strengthened, with Zaiding Pharmaceutical rising over 12%, WuXi AppTec rising over 7%, Kangnuo and Nuocheng Jianhua rising over 6%, WuXi Biologics rising over 3%, and WuXi AppTec and Junshi Biologics rising over 2%.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Novartis Pharmaceuticals rose over 150% in the US stock market before trading
- Pfizer plans to launch a drug platform directly targeting consumers
- NIO fell over 7%! Most Hong Kong listed cars weaken, Great Wall Motors: will not excessively participate in the 'price war'
- Pfizer launches drug sales platform directly targeting American patients
- Hong Kong auto stocks strengthened again in the afternoon, with NIO rising over 21%
- During the National Day holiday, Hong Kong stocks and Chinese concept stocks performed outstandingly
- Hong Kong auto stocks continue to weaken, with Ideal Auto falling more than 9%
- Hong Kong auto stocks receive market boost, Xiaopeng and Zero Run both rise by over 5%
- Pfizer plans to sell hospital drug division, company responds
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered
